Trial intelligence / Profile preview

Avastin + Chemotherapy for RAS Mutant Colorectal Liver Metastases

NCT01972490Phase 4Completed

Start
Oct 2013
Primary completion
Dec 2017
Modality
Monoclonal Antibodies
Countries
1
01

Overview

A Phase 4 trial of bevacizumab in colorectal cancer (CRC). Started Oct 2013; status: completed.

02

Drugs

bevacizumab
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT01972490.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01972490.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call